The Evidence Based Rheumatology Podcast
Health & Fitness:Medicine
In today's episode, I talk with Dr. Mehrdad Maz about the newly published guidelines for giant cell arteritis (GCA). Dr. Maz is the Division Director of the Kansas University Allergy, Clinical Immunology and Rheumatology Section. He serves on the Steering Core Committee of the ACR-VF Vasculitis Treatment Guidelines.
This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening!
E91: Clinical Innovation in Rheumatology: Past, Present, and Future
E90: There Is No Diagnosis of Exclusion in Rheumatology
E89: Vitamin D to Prevent Osteoporotic Fractures
E88: HCQ Dose Reductions and SLE Flares
E87: IVIG for Dermatomyositis
E86: Target Trials and Causality in Rheumatology
E85: Challenging Wisely
E84: The JAKapocalypse (AKA ORAL Surveillance)
E83: Effectiveness of COVID-19 Vaccines
E82: LoVAS Trial for ANCA Vasculitis
E81: Vasculitis Guidelines E7: Takayasu Arteritis with Dr. Andy Abril
E80: Vasculitis Guidelines E6 - Polyarteritis Nodosa with Dr. Jason Springer
E79: Vasculitis Guidelines E5 - GCA with Dr. Mehrdad Maz
E77: Vasculitis Guidelines #3 - ANCA Vasculitis with Dr. Sharon Chung
E76: Voclosporin for SLE Nephritis: The AURORA RCT
E75: Vasculitis Guidelines Episode 2: Overview with Sharon Chung
E74: Vasculitis Guidelines Episode 1 - Joyce Kullman
E73: Introducing the Vasculitis Guidelines Podcast
E72: Avacopan for ANCA Vasculitis
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Peter Attia Drive
The Doctor’s Farmacy with Mark Hyman, M.D.